Tourmaline Bio
Christopher Brown is an experienced Senior Director of Technical Operations with a background in downstream process technology transfer for cGMP production of clinical gene therapy candidates. Prior to their current role, Brown held positions at various companies including Ultragenyx Pharmaceutical Inc., Bioventus, Pfizer, and as an Independent Consultant focusing on bioprocess development. Christopher holds a Master's degree in Biochemistry from Boston University School of Medicine.
This person is not in any offices
Tourmaline Bio
2 followers
Tourmaline is a late-stage clinical biotechnology company driven by our mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune and inflammatory diseases. In doing so, we seek to develop assets medicines that have the potential to establish new standards-of-care in areas of high unmet medical need.